Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-25 @ 8:50 PM
Study NCT ID:
NCT00873756
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2009-03-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-05
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04
Completion Date Type:
ACTUAL
First Submit Date:
2009-03-05
First Submit QC Date:
None
Study First Post Date:
2009-04-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-01
Last Update Post Date:
2016-11-02
Last Update Post Date Type:
ESTIMATED